8.NH K， E B， S A， et al. Autoantibody profiling for lung cancer screening longitudinal retrospective analysis of CT screening cohorts.%A Trudgen K. PloS one 2014;9：e87947.
9.Jett J. et al. P2.13-013 Determination of the Detection Lead Time for Autoantibody Biomarkers in Early Stage Lung Cancer Using the UKCTOCS Cohort. Journal of Thoracic Oncology 2017;12：S2170.
10.Healey G， Murray A， Peek L， et al. Measuring the Improvement in Lung Nodule Cancer Risk Assessment when EarlyCDT-Lung is Applied to a Clinically-Tested High-Risk Cohort.
11.S Z， T J， Y H， et al. Early detection of lung cancer by using an autoantibody panel in Chinese population.%A Ren S. Oncoimmunology 2018;7：e1384108.
12.Mazzone PJ， Sears CR， Arenberg DA， et al. Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer： When Is a Biomarker Ready for Clinical Use？ An Official American Thoracic Society Policy Statement. American Journal of Respiratory & Critical Care Medicine 2017;196：e15.
13.R S， G F， A C， et al. Sensitive tumour detection and classification using plasma cell-free DNA methylomes.%A Shen SY. Nature 2018;undefined：undefined.
14.周清华，王颖，黄云超， et al.中国肺癌低剂量螺旋CT筛查指南（2018年版）.中国肺癌杂志2018.